Skip to main content
Top
Published in: Forensic Toxicology 1/2016

Open Access 01-01-2016 | Original Article

Differentiation of ring-substituted bromoamphetamine analogs by gas chromatography–tandem mass spectrometry

Authors: Hiroyuki Inoue, Shoko Negishi, Yukiko Nakazono, Yuko T. Iwata, Kenji Tsujikawa, Osamu Ohtsuru, Kazuna Miyamoto, Takuya Yamashita, Fumiyo Kasuya

Published in: Forensic Toxicology | Issue 1/2016

Login to get access

Abstract

There has been a rapid increase over the last decade in the appearance of new non-controlled psychoactive substances. Minor changes in the chemical structures of these compounds, such as the extension of an alkyl residue or replacement of a single substituent, are regularly made to avoid regulatory control, leading to the manufacture of many new potentially dangerous drugs. Bromoamphetamine analogs (bromoamphetamine [Br-AP] and bromomethamphetamine (Br-MA]) are ring-substituted amphetamines that can behave as stimulants, as well as exhibiting inhibitory activity towards monoamine oxidases in the same way as amphetamines. Gas chromatography–tandem mass spectrometry (GC–MS–MS) was used in this study to differentiate ring-substituted bromoamphetamine analogs. Free bases, trifluoroacetyl derivatives, and trimethylsilyl (TMS) derivatives of six analytes were successfully separated using DB-1ms and DB-5ms columns. Electron ionization MS–MS analysis of the TMS derivatives allowed for the differentiation of three regioisomers. TMS derivatives of 2-positional isomers provided significant product ions. The spectral patterns of 3- and 4-positional isomers were different. Chemical ionization MS–MS analysis of free bases for [M+H–HBr]+ ions at m/z 134 and 148 allowed for differentiation of the regioisomers. The spectra of 2-positional isomers contained characteristic product ions formed by dehydrogenation at m/z 132 and m/z 146 for 2Br-AP and 2Br-MA, respectively. The spectra of 3-positional isomers contained α-cleaved iminium cations as the base peaks. The spectra of 4-positional isomers showed a tropylium cation at m/z 91 as the base peak. These results demonstrate that GC–MS–MS can be used for the differentiation of regioisomeric Br-AP analogs in forensic practice.
Literature
3.
go back to reference King LA (2014) New phenethylamines in Europe. Drug Test Analysis 6:808–818CrossRef King LA (2014) New phenethylamines in Europe. Drug Test Analysis 6:808–818CrossRef
4.
go back to reference Awad T, Belal T, DeRuiter J, Kramer K, Clark CR (2009) Comparison of GC-MS and GC-IRD methods for the differentiation of methamphetamine and regioisomeric substances. Forensic Sci Int 185:67–77PubMedCrossRef Awad T, Belal T, DeRuiter J, Kramer K, Clark CR (2009) Comparison of GC-MS and GC-IRD methods for the differentiation of methamphetamine and regioisomeric substances. Forensic Sci Int 185:67–77PubMedCrossRef
5.
go back to reference Maher HM, Awas T, DeRuiter J, Kramer K, Clark CR (2012) GC-MS and GC-IRD studies on dimethoxyphenethylamines (DMPEA): regioisomers related to 2,5-DMPEA. J Chromatogr Sci 50:1–9PubMedPubMedCentralCrossRef Maher HM, Awas T, DeRuiter J, Kramer K, Clark CR (2012) GC-MS and GC-IRD studies on dimethoxyphenethylamines (DMPEA): regioisomers related to 2,5-DMPEA. J Chromatogr Sci 50:1–9PubMedPubMedCentralCrossRef
6.
go back to reference Pirisi MA, Nieddu M, Burrai L, Carta A, Briguglio I, Baralla E, Demontis MP, Varoni MV, Boatto G (2013) An LC–MS–MS method for quantitative analysis of six trimethoxyamphetamine designer drugs in rat plasma, and its application to a pharmacokinetic study. Forensic Toxicol 31:197–203CrossRef Pirisi MA, Nieddu M, Burrai L, Carta A, Briguglio I, Baralla E, Demontis MP, Varoni MV, Boatto G (2013) An LC–MS–MS method for quantitative analysis of six trimethoxyamphetamine designer drugs in rat plasma, and its application to a pharmacokinetic study. Forensic Toxicol 31:197–203CrossRef
7.
go back to reference Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (2013) Differentiation of regioisomeric fluoroamphetamine analogs by gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry. Forensic Toxicol 31:241–250CrossRef Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (2013) Differentiation of regioisomeric fluoroamphetamine analogs by gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry. Forensic Toxicol 31:241–250CrossRef
8.
go back to reference Zaitsu K, Miyagawa H, Sakamoto Y, Matsuta S, Tsuboi K, Nishioka H, Katagi M, Sato T, Tatsuno M, Tsuchihashi H, Suzuki K, Ishii A (2013) Mass spectrometric differentiation of the isomers of mono-methoxyethylamphetamines and mono-methoxydimethylamphetamines by GC–EI–MS-MS. Forensic Toxicol 31:292–300CrossRef Zaitsu K, Miyagawa H, Sakamoto Y, Matsuta S, Tsuboi K, Nishioka H, Katagi M, Sato T, Tatsuno M, Tsuchihashi H, Suzuki K, Ishii A (2013) Mass spectrometric differentiation of the isomers of mono-methoxyethylamphetamines and mono-methoxydimethylamphetamines by GC–EI–MS-MS. Forensic Toxicol 31:292–300CrossRef
9.
go back to reference Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (2014) Simultaneous determination of tryptamine analogs in designer drugs using gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry. Forensic Toxicol 32:154–161CrossRef Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (2014) Simultaneous determination of tryptamine analogs in designer drugs using gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry. Forensic Toxicol 32:154–161CrossRef
10.
go back to reference Negishi S, Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (2014) Differentiation of regioisomeric methylamphetamines by GC-MS. Jpn J Forensic Sci Tech 19:111–1197 (in Japanese) CrossRef Negishi S, Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (2014) Differentiation of regioisomeric methylamphetamines by GC-MS. Jpn J Forensic Sci Tech 19:111–1197 (in Japanese) CrossRef
11.
go back to reference Kusano M, Zaitsu K, Nakayama H, Nakajima J, Hisatsune K, Moriyasu T, Matsuta S, Katagi M, Tsuchihashi H, Ishii A (2015) Positional isomer differentiation of synthetic cannabinoid JWH-081 by GC-MS/MS. J Mass Spectrom 50:586–591PubMedCrossRef Kusano M, Zaitsu K, Nakayama H, Nakajima J, Hisatsune K, Moriyasu T, Matsuta S, Katagi M, Tsuchihashi H, Ishii A (2015) Positional isomer differentiation of synthetic cannabinoid JWH-081 by GC-MS/MS. J Mass Spectrom 50:586–591PubMedCrossRef
12.
go back to reference Thaxton A, Belal TS, Smith F, DeRuiter J, Abdel-Hay KM, Clark CR (2015) Mass spectral studies on 1-n-pentyl-3-(1-naphthoyl)indole (JWH-018), three deuterium-labeled analogues and the inverse isomer 1-naphthoyl-3-n-pentylindole. Rapid Commun Mass Spectrom 29:871–877PubMed Thaxton A, Belal TS, Smith F, DeRuiter J, Abdel-Hay KM, Clark CR (2015) Mass spectral studies on 1-n-pentyl-3-(1-naphthoyl)indole (JWH-018), three deuterium-labeled analogues and the inverse isomer 1-naphthoyl-3-n-pentylindole. Rapid Commun Mass Spectrom 29:871–877PubMed
13.
go back to reference Glennon RA, Raghupathi R, Bartyzel P, Teitler M, Leonhardt S (1992) Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. J Med Chem 35:734–740PubMedCrossRef Glennon RA, Raghupathi R, Bartyzel P, Teitler M, Leonhardt S (1992) Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. J Med Chem 35:734–740PubMedCrossRef
14.
go back to reference Aldous FAB, Barrass BC, Brewster K, Buxton DA, Green DM, Pinder RM, Rich P, Skeels M (1974) Structure-activity relationships in psychotomimetic phenylalkylamines. J Med Chem 17:1100–1111PubMedCrossRef Aldous FAB, Barrass BC, Brewster K, Buxton DA, Green DM, Pinder RM, Rich P, Skeels M (1974) Structure-activity relationships in psychotomimetic phenylalkylamines. J Med Chem 17:1100–1111PubMedCrossRef
15.
go back to reference Fuller RW, Baker JC, Perry KW, Molloy BB (1975) Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: drug levels in brain and effects on brain serotonin metabolism. Neuropharmacology 14:739–746PubMedCrossRef Fuller RW, Baker JC, Perry KW, Molloy BB (1975) Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: drug levels in brain and effects on brain serotonin metabolism. Neuropharmacology 14:739–746PubMedCrossRef
16.
go back to reference Harvey JA, McMaster SE, Fuller RW (1977) Comparison between the neurotoxic and serotonin-depleting effects of various halogenated derivatives of amphetamine in the rat. J Pharmacol Exp Ther 202:581–589PubMed Harvey JA, McMaster SE, Fuller RW (1977) Comparison between the neurotoxic and serotonin-depleting effects of various halogenated derivatives of amphetamine in the rat. J Pharmacol Exp Ther 202:581–589PubMed
17.
18.
go back to reference Leonard BE, Shallice SA (1971) Some neurochemical effects of amphetamine, methylamphetamine and p-bromomethylamphetamine in the rat. Br J Pharmacol 41:198–212PubMedPubMedCentralCrossRef Leonard BE, Shallice SA (1971) Some neurochemical effects of amphetamine, methylamphetamine and p-bromomethylamphetamine in the rat. Br J Pharmacol 41:198–212PubMedPubMedCentralCrossRef
19.
go back to reference Juvancz P (1981) The effect of p-bromomethamphetamine (V-111) on sleep in the rat. Eur J Pharm 70:461–466CrossRef Juvancz P (1981) The effect of p-bromomethamphetamine (V-111) on sleep in the rat. Eur J Pharm 70:461–466CrossRef
20.
go back to reference Knoll J, Vizi ES (1970) Cross-tolerance between para-bromo-methamphetamine (V-111) and LSD-25. Pharmacology 4:278–286PubMedCrossRef Knoll J, Vizi ES (1970) Cross-tolerance between para-bromo-methamphetamine (V-111) and LSD-25. Pharmacology 4:278–286PubMedCrossRef
21.
go back to reference Knoll J, Vizi ES, Knoll B (1970) Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD. Acta Physiol Acad Sci Hung 37:151–170PubMed Knoll J, Vizi ES, Knoll B (1970) Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD. Acta Physiol Acad Sci Hung 37:151–170PubMed
23.
go back to reference DeRuiter J, Clark CR (1998) Gas chromatographic-mass spectrometric and high-performance liquid chromatographic analyses of the bromination products of the regioisomeric dimethoxyphenethylamines: differentiation of Nexus from five positional isomers. J Chromatogr Sci 36:23–28CrossRef DeRuiter J, Clark CR (1998) Gas chromatographic-mass spectrometric and high-performance liquid chromatographic analyses of the bromination products of the regioisomeric dimethoxyphenethylamines: differentiation of Nexus from five positional isomers. J Chromatogr Sci 36:23–28CrossRef
24.
go back to reference DeRuiter J, Holston P, Clark CR (1998) Liquid chromatographic and mass spectral methods of identification for regioisomeric dimethoxyamphetamines and brominated dimethoxyamphetamines. J Chromatogr Sci 36:73–79CrossRef DeRuiter J, Holston P, Clark CR (1998) Liquid chromatographic and mass spectral methods of identification for regioisomeric dimethoxyamphetamines and brominated dimethoxyamphetamines. J Chromatogr Sci 36:73–79CrossRef
25.
go back to reference Taniguchi M, Yamamoto Y, Nishi K (2010) A technique combining trifluoroacetyl derivatization and gas chromatography-mass spectrometry to distinguish methamphetamine and its 4-substituted analogs. J Mass Spectrom 45:1473–1476PubMedCrossRef Taniguchi M, Yamamoto Y, Nishi K (2010) A technique combining trifluoroacetyl derivatization and gas chromatography-mass spectrometry to distinguish methamphetamine and its 4-substituted analogs. J Mass Spectrom 45:1473–1476PubMedCrossRef
26.
go back to reference Taniguchi M, Yamamoto Y, Nishi K (2013) Comparative in Vitro studies of the metabolism of six 4-substituted methamphetamines and their inhibition of cytochrome P450 2D6 by GC-MS with trifluoroacetyl derivatization. Am J Anal Chem 4:166–175CrossRef Taniguchi M, Yamamoto Y, Nishi K (2013) Comparative in Vitro studies of the metabolism of six 4-substituted methamphetamines and their inhibition of cytochrome P450 2D6 by GC-MS with trifluoroacetyl derivatization. Am J Anal Chem 4:166–175CrossRef
27.
go back to reference Westphal F, Rösner P, Junge Th (2010) Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry. Forensic Sci Int 194:53–59PubMedCrossRef Westphal F, Rösner P, Junge Th (2010) Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry. Forensic Sci Int 194:53–59PubMedCrossRef
28.
go back to reference Negishi S, Nakazono Y, Iwata YT, Kanamori T, Tsujikawa K, Kuwayama K, Yamamuro T, Miyamoto K, Yamashita T, Kasuya F, Inoue H (2015) Differentiation of regioisomeric chloroamphetamine analogs using gas chromatography-chemical ionization-tandem mass spectrometry. Forensic Toxicol 33:338–347PubMedPubMedCentralCrossRef Negishi S, Nakazono Y, Iwata YT, Kanamori T, Tsujikawa K, Kuwayama K, Yamamuro T, Miyamoto K, Yamashita T, Kasuya F, Inoue H (2015) Differentiation of regioisomeric chloroamphetamine analogs using gas chromatography-chemical ionization-tandem mass spectrometry. Forensic Toxicol 33:338–347PubMedPubMedCentralCrossRef
Metadata
Title
Differentiation of ring-substituted bromoamphetamine analogs by gas chromatography–tandem mass spectrometry
Authors
Hiroyuki Inoue
Shoko Negishi
Yukiko Nakazono
Yuko T. Iwata
Kenji Tsujikawa
Osamu Ohtsuru
Kazuna Miyamoto
Takuya Yamashita
Fumiyo Kasuya
Publication date
01-01-2016
Publisher
Springer Japan
Published in
Forensic Toxicology / Issue 1/2016
Print ISSN: 1860-8965
Electronic ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-015-0296-3

Other articles of this Issue 1/2016

Forensic Toxicology 1/2016 Go to the issue